4 completed, 1 recruiting, 1 unknown. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Indigestion: new trials by email Literature Review of Indigestion trials Research Report on Indigestion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia Ondansetron 8mg, Placebo - Indigestion, Diabetes Mellitus | Phase 2 | Recruiting | Mayo Clinic | 150 | 2019-04-02 | 2026-05-04 |
| Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms Probiotic dietary supplement (Trenev Trio®), placebo - Gastrointestinal Symptoms, Bloating | Phase 2 / Phase 3 | Completed | University of Maryland, Baltimore | 80 | 2014-12-01 | 2021-09-14 |
| Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. Secretol, Nexium - Gastroesophageal Reflux Disease (GERD), Heartburn | Phase 1 / Phase 2 | Unknown | Effexus Pharmaceutical | 40 | 2010-05-01 | 2014-08-05 |
| NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar NAET Testing Modalities - Allergy, Fatigue | Phase 1 / Phase 2 | Completed | Nambudripad's Allergy Research Foundation | 75 | 2005-01-01 | 2008-10-17 |
| YM443 in Subjects With Functional Dyspepsia YM443 - Indigestion, Nausea | Phase 2 | Completed | Astellas Pharma Inc | 416 | 2004-03-10 | 2018-01-10 |
| Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients Esomeprazole, Placebo - Indigestion | Phase 2 | Completed | University of Kansas Medical Center | 73 | 2003-10-01 | 2019-11-27 |
Dyspepsia (6) · Abdominal Pain (1) · Diabetes Mellitus (1) · Fatigue (1) · Gastroesophageal Reflux (1) · Heartburn (1) · Hyperglycemia (1) · Hypersensitivity (1) · Hypoglycemia (1) · Mucopolysaccharidosis IV (1) · Nausea (1)
Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Signs and Symptoms, Digestive (6) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Glucose Metabolism Disorders (2) · Carbohydrate Metabolism, Inborn Errors (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Gastrointestinal Diseases (1)
Esomeprazole (2) · Lansoprazole (1) · Ondansetron (1)
Astellas Pharma Inc (1) · Effexus Pharmaceutical (1) · Mayo Clinic (1) · Nambudripad's Allergy Research Foundation (1) · University of Kansas Medical Center (1) · University of Maryland, Baltimore (1)
United States (5)
Adil E Bharucha, MD (1) · Chris D'Adamo, PhD (1) · Devi S Nambudripad, DC,L.Ac,PhD (1) · Jerzy Sarosiek, PhD (1) · Richard Mccallum, MD (1) · Ronnie Fass, MD (1)
P01DK068055 (1)